Burkitt lymphoma with a granulomatous reaction: an M1/ Th1-polarised microenvironment is associated with controlled growth and spontaneous regression lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regression
暂无分享,去创建一个
C. Agostinelli | S. Lazzi | L. Mundo | M. Granai | B. Puccini | Leah Mnango | Sabattini | Marafioti | M. Ponzoni | Falko Fend | Ester Sorrentino | Virginia Mancini | Stephan Dirnhofer | Raffaella Guazzo | G. Cevenini | Lorenzo Leoncini | Leticia Quintanilla‑Martinez | Ayse Akarca | R. Santi | F. Vergoni | Claudio Tripodo | Gioia Di Stefano | Elena | ulay Tecimer | Ahu Senem | Demiroz | Teresa
[1] A. Akarca,et al. Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program , 2020, Infectious Agents and Cancer.
[2] K. Naresh,et al. Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature , 2019, Haematologica.
[3] V. Ranzani,et al. Eomesodermin controls a unique differentiation program in human IL‐10 and IFN‐γ coproducing regulatory T cells , 2018, European journal of immunology.
[4] J. T. Afshari,et al. Macrophage plasticity, polarization, and function in health and disease , 2018, Journal of cellular physiology.
[5] A. Rosenwald,et al. The clinicopathologic spectrum of mature aggressive B cell lymphomas , 2017, Virchows Archiv.
[6] V. A. Stewart,et al. Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study , 2016, PloS one.
[7] David C Park,et al. Novel insights into the early histopathogenesis of immunodeficiency‐associated Burkitt lymphoma: a case report of Burkitt microlymphoma arising within HIV lymphadenitis , 2016, Histopathology.
[8] Burton E. Barnett,et al. Cutting Edge: B Cell–Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection , 2016, The Journal of Immunology.
[9] P. Piccaluga,et al. The cell of origin of Burkitt lymphoma: germinal centre or not germinal centre? , 2016, Histopathology.
[10] S. Pileri,et al. Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma , 2015, American journal of clinical pathology.
[11] S. Pileri,et al. Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma , 2015, PLoS pathogens.
[12] M. Nussenzweig,et al. Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma , 2015, Cell.
[13] M. Meyerson,et al. The tumor virus landscape of AIDS-related lymphomas. , 2015, Blood.
[14] H. Einsele,et al. Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT. , 2015, Blood.
[15] Hongwei Liang,et al. Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance , 2014, Front. Immunol..
[16] Wenyan Zhang,et al. HIV-related Burkitt lymphoma with florid granulomatous reaction: an unusual case with good outcome. , 2014, International journal of clinical and experimental pathology.
[17] Yong-ming Yao,et al. Macrophage Polarization in Inflammatory Diseases , 2014, International journal of biological sciences.
[18] B. Kempkes,et al. Macrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages , 2013, PloS one.
[19] T. Decker,et al. The regulation of inflammation by interferons and their STATs , 2013, JAK-STAT.
[20] E. Vigorito,et al. Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma , 2012, Blood Cancer Journal.
[21] Graham M. Lord,et al. T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements , 2012, Nature Communications.
[22] A. Rosato,et al. The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders , 2010, Haematologica.
[23] Lionel B Ivashkiv,et al. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. , 2009, Immunity.
[24] H. Zebroski,et al. Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers. , 2007, Blood.
[25] B. Walker,et al. Differential targeting and shifts in the immunodominance of Epstein-Barr virus--specific CD8 and CD4 T cell responses during acute and persistent infection. , 2005, The Journal of infectious diseases.
[26] S. Pileri,et al. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. , 2005, Blood.
[27] E. Jaffe,et al. Granulomatous reaction in Burkitt lymphoma: correlation with EBV positivity and clinical outcome. , 2005, The American journal of surgical pathology.
[28] C. Münz. Epstein-Barr Virus Nuclear Antigen 1 , 2004, The Journal of experimental medicine.
[29] E. Haralambieva,et al. Florid Granulomatous Reaction in Epstein-Barr Virus-positive Nonendemic Burkitt Lymphomas: Report of Four Cases , 2004, The American journal of surgical pathology.
[30] R. Fåhraeus,et al. Self-Inhibition of Synthesis and Antigen Presentation by Epstein-Barr Virus-Encoded EBNA1 , 2003, Science.
[31] P. Kidd. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. , 2003, Alternative medicine review : a journal of clinical therapeutic.
[32] S. Stevanović,et al. Epstein-Barr Nuclear Antigen 1-Specific CD4+ Th1 Cells Kill Burkitt’s Lymphoma Cells1 , 2002, The Journal of Immunology.
[33] E. Bloemena,et al. Differential Immunogenicity of Epstein-Barr Virus Latent-Cycle Proteins for Human CD4+ T-Helper 1 Responses , 2001, Journal of Virology.
[34] Kristi Kincaid,et al. M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.
[35] R. Steinman,et al. Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1 , 2000, The Journal of experimental medicine.
[36] T. Langmann,et al. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro‐ and antiinflammatory stimuli , 2000, Journal of leukocyte biology.
[37] L. Frappier,et al. Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. , 1997, Immunity.
[38] P. Cresswell,et al. Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs. , 1997, Journal of immunology.
[39] E. Jaffe,et al. Small Noncleaved Cell Lymphoma Associated with Florid Epithelioid Granulomatous Response: A Clinicopathologic Study of Seven Patients , 1993, The American journal of surgical pathology.
[40] B. Nathwani,et al. Hodgkin's disease occurring in monocytoid B-cell clusters. , 1991, American journal of clinical pathology.
[41] Keith E Steele,et al. Multiplex Immunohistochemistry for Image Analysis of Tertiary Lymphoid Structures in Cancer. , 2018, Methods in molecular biology.
[42] P. Babál,et al. Burkitt lymphoma with unusual granulomatous reaction. A case report. , 2011, Ceskoslovenska patologie.
[43] H. Stein,et al. T-bet-positive and IRTA1-positive monocytoid B cells differ from marginal zone B cells and epithelial-associated B cells in their antigen profile and topographical distribution. , 2005, Haematologica.
[44] M. Hansmann,et al. Monocytoid B-cells occurring in Hodgkin's disease , 2004, Virchows Archiv.
[45] R. Steinman,et al. EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function. , 2001, The Journal of clinical investigation.